Description

5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-6-Yl)-Pentanoic Acid Methyl Ester is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for ensuring the quality and consistency of final active pharmaceutical ingredients (APIs) in sophisticated synthesis pathways. It is primarily required by research institutions and manufacturers in the pharmaceutical and biotechnology sectors for the development and production of novel therapeutic agents.

Application

• Key Intermediate in Biotin Analog Synthesis: Serves as a crucial building block in the multi-step synthesis of biotin (Vitamin B7) and its various structural analogs.
• Pharmaceutical Research & Development (R&D): Used in medicinal chemistry for the discovery and optimization of new drug candidates targeting specific enzymes and metabolic pathways.
• API Manufacturing: Employed in the controlled, large-scale production of active pharmaceutical ingredients where the thienoimidazolone core is a required pharmacophore.
• Biochemical Probe Development: Utilized in life science research to create labeled compounds or probes for studying biological recognition and binding events.
• Fine Chemical Synthesis: Acts as a specialized synthon for constructing complex molecular architectures in advanced organic chemistry applications.

Basic Information

Product Name	5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-6-Yl)-Pentanoic Acid Methyl Ester
CAS No.	875237-68-6
Molecular Formula	C12H18N2O3S
Molecular Weight	270.35 g/mol
Synonyms	Methyl 5-(2-oxohexahydrothieno[3,4-d]imidazol-6-yl)pentanoate; Biotin Methyl Ester Intermediate; Hexahydro-2-oxothieno[3,4-d]imidazole-6-pentanoic Acid Methyl Ester; 6-(Methoxycarbonylpentyl)-2-oxo-hexahydrothieno[3,4-d]imidazole; D-Biotin Methyl Ester Synthetic Precursor
EINECS	Contact for details

Quality Control

Our 5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-6-Yl)-Pentanoic Acid Methyl Ester is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets exacting standards for pharmaceutical intermediate use. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed after opening to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.